LANEASHA EUDELL: Open Payments
NPI 1811407745 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,878 in 40 payments from 8 companies in 2025. Trend: 2023 $4,100 · 2024 $2,661 · 2025 $1,878
Food & beverage: $1,878
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $774 |
| Teva Pharmaceuticals USA, Inc. | 6 | $375 |
| Axsome Therapeutics, Inc. | 2 | $179 |
| Alkermes, Inc. | 5 | $176 |
| Otsuka America Pharmaceutical, Inc. | 4 | $164 |
| Neurocrine BioSciences, Inc. | 1 | $113 |
| Lundbeck LLC | 3 | $58 |
| ABBVIE INC. | 2 | $38 |
Products named: CAPLYTA, AUSTEDO XR, REXULTI, Auvelity, UZEDY, LYBALVI, INGREZZA, ARISTADA.
Industry payments across NY — which companies pay providers there.
